U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. CPG Sec. 430.300 Labeling Shipping Containers of Drugs
  1. Search for FDA Guidance Documents

GUIDANCE DOCUMENT

CPG Sec. 430.300 Labeling Shipping Containers of Drugs May 1987

Final
Docket Number:
None found
Issued by:
Guidance Issuing Office
Center for Drug Evaluation and Research

BACKGROUND:

Because of the pilferage problem, some firms prefer not to name the drugs on shipping containers, so that *their contents are not easily determined*. Questions have been raised as to whether or not the FDC Act requires mandatory label information on such shipping containers.

POLICY:

If the outer carton is used only to protect the goods during shipment and is stripped away by the consignee, then the FDC Act does not require any information to be stated on such shipping carton.

*Material between asterisks is new or revised*

Issued:7/12/76 as 7132b.12
Revised: 10/1/80, 5/22/87

Submit Comments

Submit Comments Online

You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All written comments should be identified with this document's docket number: None found.

Back to Top